nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3
|
Tao, Tao |
|
2000 |
18 |
14 |
p. 1359-1366 8 p. |
artikel |
2 |
Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes
|
Vera Bravo, Ricardo |
|
2000 |
18 |
14 |
p. 1289-1293 5 p. |
artikel |
3 |
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults
|
Halperin, Scott A. |
|
2000 |
18 |
14 |
p. 1312-1319 8 p. |
artikel |
4 |
A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naı̈ve and infection-primed mice
|
Ruitenberg, Kirsten M. |
|
2000 |
18 |
14 |
p. 1367-1373 7 p. |
artikel |
5 |
Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast
|
Milek, Richard L.B |
|
2000 |
18 |
14 |
p. 1402-1411 10 p. |
artikel |
6 |
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination
|
Matsuo, Kazutoshi |
|
2000 |
18 |
14 |
p. 1344-1350 7 p. |
artikel |
7 |
Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus
|
Bouma, A. |
|
2000 |
18 |
14 |
p. 1374-1381 8 p. |
artikel |
8 |
Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination
|
Bautista-López, Norma |
|
2000 |
18 |
14 |
p. 1393-1401 9 p. |
artikel |
9 |
Early immunisation with hepatitis B vaccine: a five-year study
|
Belloni, Cesare |
|
2000 |
18 |
14 |
p. 1307-1311 5 p. |
artikel |
10 |
Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection
|
Bernstein, David I |
|
2000 |
18 |
14 |
p. 1351-1358 8 p. |
artikel |
11 |
Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella
|
Tischer, A |
|
2000 |
18 |
14 |
p. 1382-1392 11 p. |
artikel |
12 |
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys
|
Rouppe van der Voort, Eileene |
|
2000 |
18 |
14 |
p. 1334-1343 10 p. |
artikel |
13 |
Index
|
|
|
2000 |
18 |
14 |
p. XII-XXI nvt p. |
artikel |
14 |
Index
|
|
|
2000 |
18 |
14 |
p. I-XI nvt p. |
artikel |
15 |
Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes
|
Arkema, Annemarie |
|
2000 |
18 |
14 |
p. 1327-1333 7 p. |
artikel |
16 |
Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by recombinant Bacillus Catmette-Guérin (BCG)
|
Ohara, Naoya |
|
2000 |
18 |
14 |
p. 1294-1297 4 p. |
artikel |
17 |
Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi
|
Wrightsman, Ruth A |
|
2000 |
18 |
14 |
p. 1419-1427 9 p. |
artikel |
18 |
Patent report
|
|
|
2000 |
18 |
14 |
p. 1428- 1 p. |
artikel |
19 |
Patent report
|
|
|
2000 |
18 |
14 |
p. 1428- 1 p. |
artikel |
20 |
Patent report
|
|
|
2000 |
18 |
14 |
p. 1429- 1 p. |
artikel |
21 |
Patent report
|
|
|
2000 |
18 |
14 |
p. 1428-1429 2 p. |
artikel |
22 |
Patent report
|
|
|
2000 |
18 |
14 |
p. 1428- 1 p. |
artikel |
23 |
Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model
|
Stack, Anne M |
|
2000 |
18 |
14 |
p. 1412-1418 7 p. |
artikel |
24 |
Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme
|
Huemer, Hartwig P. |
|
2000 |
18 |
14 |
p. 1320-1326 7 p. |
artikel |
25 |
Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains
|
Marshall, David G |
|
2000 |
18 |
14 |
p. 1298-1306 9 p. |
artikel |